遠大醫藥(00512.HK)腎上腺素注射筆Jext獲大灣區急需進口藥品批件
遠大醫藥(00512.HK)公布,集團用於治療嚴重過敏反應的Jext預充式腎上腺素自動注射筆獲廣東省藥品監督管理局正式批准,獲得粵港澳大灣區內地臨床急需進口港澳藥品批件,產品可在大灣區內指定醫療機構進行使用。此次在大灣區獲批彌補了內地市場的空白,為有嚴重過敏史患者提供一種有效的自我救治方式。
Jext預充式腎上腺素自動注射筆是一款內含腎上腺素無菌溶液的一次性自動注射器,已在西班牙、英國、法國、德國和韓國等21個國家或地區獲批上市,全球範圍內上市使用超過十年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.